Accuray Incorporated (ARAY)Healthcare | Medical Devices | Madison, United States | NasdaqCM
0.19 USD
-0.03
(-12.826%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 0.19 0.00 (0.000%) ⇩ (Oct. 13, 2026, 6:56 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 9:22 a.m. EDT
The investment case for Accuray is currently broken on both the immediate and long-term fronts, driven by a perfect storm of deteriorating fundamentals and a hostile market structure. Long-term, the business is failing to generate value. Revenue has contracted by nearly 21% year-over-year, and the company is bleeding cash with negative operating cash flow and a massive debt load relative to equity. The stock has lost over 70% of its value over the last nine years, and despite a slight uptick in the most recent annual comparison, the trailing twelve months show a 33% drop in share price. The market has correctly identified this as a value trap; the low price-to-book ratio is not a bargain, but a reflection of the company's inability to sustain operations. With no dividend to provide income, there is no floor for the downside other than bankruptcy or acquisition at a distressed price. Short-term, the momentum is decisively negative. The stock is trading significantly below its 50-day and 200-day moving averages, confirming a prolonged downtrend. The options market offers no hope for a bounce; the complete absence of call buying suggests that even traders are not willing to risk capital on a reversal. Instead, the heavy put open interest at the $0.50 strike acts as a self-fulfilling prophecy, capping any potential rally. The statistical forecasting models also register a weak signal, aligning with the broader picture of uncertainty and lack of direction. In summary, Accuray presents a high-risk profile with no catalyst for recovery visible in the data. The combination of shrinking revenues, deep losses, and a stock price that has halved in the last year makes it a clear 'avoid' for both swing traders and long-term holders. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.137369 |
| AutoARIMA | 0.141865 |
| MSTL | 0.145121 |
| AutoTheta | 0.265139 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 0.26 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.630 |
| Excess Kurtosis | -0.70 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 440.955 |
| Revenue per Share | 3.278 |
| Market Cap | 22,729,300 |
| Forward P/E | -0.79 |
| Beta | 1.42 |
| Profit Margins | -12.24% |
| Website | https://www.accuray.com |
As of Oct. 10, 2026, 9:22 a.m. EDT: Speculators are overwhelmingly positioned for downside protection rather than upside speculation. Call activity is virtually nonexistent across all expirations, with zero volume or open interest recorded for strikes above the money. Conversely, put buyers are active, particularly at the $0.50 strike, which represents a significant distance from current prices. This heavy skew toward selling puts indicates a market consensus expecting further weakness or stagnation, with no speculative capital attempting to bet on a recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.878453 |
| Address1 | 1,240 Deming Way |
| All Time High | 31.09 |
| All Time Low | 0.21 |
| Ask | 0.2153 |
| Ask Size | 1 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 3,535,360 |
| Average Daily Volume3 Month | 7,285,538 |
| Average Volume | 7,285,538 |
| Average Volume10Days | 3,535,360 |
| Beta | 1.419 |
| Bid | 0.1608 |
| Bid Size | 1 |
| Board Risk | 5 |
| Book Value | 0.349 |
| City | Madison |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 5 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.1903 |
| Current Ratio | 1.503 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 0.2148 |
| Day Low | 0.1855 |
| Debt To Equity | 440.955 |
| Display Name | Accuray |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,787,171,400 |
| Earnings Call Timestamp Start | 1,787,171,400 |
| Earnings Timestamp | 1,787,169,600 |
| Earnings Timestamp End | 1,793,822,400 |
| Earnings Timestamp Start | 1,793,822,400 |
| Ebitda | -3,528,000 |
| Ebitda Margins | -0.00878 |
| Enterprise To Ebitda | -47.047 |
| Enterprise To Revenue | 0.413 |
| Enterprise Value | 165,980,304 |
| Eps Forward | -0.24 |
| Eps Trailing Twelve Months | -0.4 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 608 824 2996 |
| Fifty Day Average | 0.2646 |
| Fifty Day Average Change | -0.074300006 |
| Fifty Day Average Change Percent | -0.28080124 |
| Fifty Two Week Change Percent | -87.8453 |
| Fifty Two Week High | 1.86 |
| Fifty Two Week High Change | -1.6697 |
| Fifty Two Week High Change Percent | -0.89768815 |
| Fifty Two Week Low | 0.1855 |
| Fifty Two Week Low Change | 0.0048000067 |
| Fifty Two Week Low Change Percent | 0.025876047 |
| Fifty Two Week Range | 0.1855 - 1.86 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,170,945,000,000 |
| Float Shares | 113,610,669 |
| Forward Eps | -0.24 |
| Forward P E | -0.7929167 |
| Free Cashflow | 10,565,625 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 809 |
| Fullday Change | -0.028400004 |
| Fullday Change Percent | -13.009622 |
| Fullday Price | 0.1903 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.27729 |
| Gross Profits | 111,454,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04235 |
| Held Percent Institutions | 0.64609003 |
| Implied Shares Outstanding | 119,439,307 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://investors.accuray.com/phoenix.zhtml?c=177244&p=irol-irhome |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,782,777,600 |
| Long Business Summary | Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, a tailored helical solution, which integrates radiation treatment planning, delivery, imaging, and data management; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin. |
| Long Name | Accuray Incorporated |
| Market | us_market |
| Market Cap | 22,729,300 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_739115 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -49,194,000 |
| Next Fiscal Year End | 1,814,313,600 |
| Non Diluted Market Cap | 26,951,479 |
| Open | 0.212 |
| Operating Cashflow | -6,981,000 |
| Operating Margins | 0.062140003 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Peg Ratio | 29.49 |
| Phone | 608 824 2800 |
| Post Market Change | -0.00040000677 |
| Post Market Change Percent | -0.21019799 |
| Post Market Price | 0.1899 |
| Post Market Time | 1,791,932,171 |
| Previous Close | 0.2183 |
| Price Hint | 4 |
| Price To Book | 0.54527223 |
| Price To Sales Trailing12 Months | 0.056548003 |
| Profit Margins | -0.12239 |
| Quick Ratio | 0.661 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.028 |
| Regular Market Change Percent | -12.8264 |
| Regular Market Day High | 0.2148 |
| Regular Market Day Low | 0.1855 |
| Regular Market Day Range | 0.1855 - 0.2148 |
| Regular Market Open | 0.212 |
| Regular Market Previous Close | 0.2183 |
| Regular Market Price | 0.1903 |
| Regular Market Time | 1,791,921,601 |
| Regular Market Volume | 3,243,480 |
| Return On Assets | -0.014049999 |
| Return On Equity | -0.80076 |
| Revenue Growth | -0.209 |
| Revenue Per Share | 3.278 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 119,439,307 |
| Shares Percent Shares Out | 0.0619 |
| Shares Short | 7,388,578 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 4,993,743 |
| Short Name | Accuray Incorporated |
| Short Percent Of Float | 0.0709 |
| Short Ratio | 0.4 |
| Source Interval | 15 |
| State | WI |
| Symbol | ARAY |
| Total Cash | 40,623,000 |
| Total Cash Per Share | 0.34 |
| Total Debt | 183,874,000 |
| Total Revenue | 401,947,008 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.4 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.4184 |
| Two Hundred Day Average Change | -0.22809999 |
| Two Hundred Day Average Change Percent | -0.5451721 |
| Type Disp | Equity |
| Volume | 3,243,480 |
| Website | https://www.accuray.com |
| Zip | 53,717-1954 |